|
Product complaint number: (b)(4).Date sent to the fda: 5/11/2022 this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.The following information was requested, but was unavailable: please provide procedure name and date no further information is available.Please provide lot number =>no further information is available.Please provide the return status of the device(s) as it has not been received for analysis.If the device has been shipped, please provide the shipment tracking details.We regularly contact with sales rep about the device returning.No further information will be provided.Investigation summary: the product was returned for evaluation.Ethicon inc conducted a visual inspection of the sample returned.Visual analysis of the returned product revealed that one opened sample product code sxpp1a200 was received for evaluation.Upon visual inspection of the returned sample, the suture barbs were to be damaged at the tips, in addition, the fixation tab was observed to have a side broken.After further evaluation of the fixation tab crimping marks were observed on the tab possibly from a surgical device.It should be noted that a 100% inspection is performed via automotive vision system to ensure the tab is present and complete during manufacturing.The manufacturing records couldn't be reviewed as the batch number is unknown.As part of ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.This is a combination product, and the event has been reviewed for both the suture and the triclosan.Trade name -irgacare.Active ingredient(s)- triclosan.Dosage form - suture/solid/parenteral.Strength - = 2360 g /m.
|